Drug Drug Interaction Study

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Amgen
AmgenTHOUSAND OAKS, CA
1 program
1
Rivaroxaban 20mgPhase 41 trial
Active Trials
NCT06314763Completed21Est. Mar 2024

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
AmgenRivaroxaban 20mg

Clinical Trials (1)

Total enrollment: 21 patients across 1 trials

NCT06314763AmgenRivaroxaban 20mg

Rivaroxaban Sotorasib Interaction Study

Start: Nov 2023Est. completion: Mar 202421 patients
Phase 4Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space